Home Newsfeeds DoD Issues $24.8M Critical Minerals Award To Perpetua Resources

DoD Issues $24.8M Critical Minerals Award To Perpetua Resources

DoD Issues $24.8M Critical Minerals Award to Perpetua Resources > U.S. Department of Defense > Release

byBenzinga Newsdesk

December 19, 2022

1 minute read

DoD Issues $24.8M Critical Minerals Award to Perpetua Resources > U.S. Department of Defense > Release

So Does Elon Musk’s Tesla Or Lucid Make The Cooler-Looking Electric Vehicle?

By Henry Khederian

September 20, 9:31 AM

Every week, Benzinga conducts a survey to find out what traders are most excited, interested or thinking about when they are managing and building their personal portfolios.

LCID

Parsons Corp Expects FY24 Revenue of $5.8B-$6.0B Vs $5.64B Est, Now Expects FY25 Revenue Growth of Mid-Single-Digit Organic Growth or Better+M&A (Prior 4%-6%)

By Benzinga Newsdesk

February 14, 7:36 AM

Fiscal Year 2024 Guidance The table below summarizes the company's fiscal year 2024 guidance. Fiscal Year 2024 Guidance Revenue $5.8 billion - $6.0

PSN

HealthEquity’s High-Margin HSA Assets: Analyst’s Perspective On Their Impact On Revenue

By Nabaparna Bhattacharya

June 12, 2:39 PM

KeyBanc Capital Markets analyst Scott Schoenhaus reiterated an Overweight rating on the shares of HealthEquity, Inc. (NASDAQ: HQY), with a

HQY

Goldman Sachs Maintains Neutral on Dun & Bradstreet Hldgs, Lowers Price Target to $15

By Benzinga Newsdesk

November 7, 9:06 AM

Goldman Sachs analyst George Tong maintains Dun & Bradstreet Hldgs (NYSE:DNB) with a Neutral and lowers the price target from $17 to $15.

DNB

DoD Issues $24.8M Critical Minerals Award To Perpetua Resources

Related Posts

So Does Elon Musk’s Tesla Or Lucid Make The Cooler-Looking Electric Vehicle?

Parsons Corp Expects FY24 Revenue of $5.8B-$6.0B Vs $5.64B Est, Now Expects FY25 Revenue Growth of Mid-Single-Digit Organic Growth or Better+M&A (Prior 4%-6%)

HealthEquity’s High-Margin HSA Assets: Analyst’s Perspective On Their Impact On Revenue

Goldman Sachs Maintains Neutral on Dun & Bradstreet Hldgs, Lowers Price Target to $15